An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the onset and duration of action of two
concentrations of AKF-1 Ophthalmic Solution compared to vehicle in the conjunctival allergen
challenge (CAC) model of acute allergic conjunctivitis.